Gelteq Ltd (GELS) stock
GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.27−0.09 (-25.05%)
Close on Nov 17, 2026Market cap $2.88MP/E –Yield –
Gelteq price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Gelteq's price to sales ratio was 34.3× on Nov 11, 2026, against 92.3× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 34.3× | −32.9 |
| 2025 | Dec 31, 2025 | 67.1× | – |
See a number that looks wrong?